콜마바이오텍
215380KOSDAQ· 연구개발업2,160원+40 (+1.89%)전일 종가 2026-09-18
52주 위치
1,6164,53519%신고가 대비 -52.37%
- 시가총액
- 364억
- PER
- 29.19
- PBR
- 1.37
- EPS(TTM)
- 74원
- BPS
- 1,579원
- 자사주비율
- 0.95%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021(별도) | 2022(별도) | 2023(별도) | 2024(별도) | 2025(별도) |
|---|---|---|---|---|---|
| ROE | -6.12% | -6.15% | -19.55% | 0.88% | -21.03% |
| ROA | -1.92% | -1.93% | -5.23% | 0.23% | -6.11% |
| 영업이익률 | -11.29% | -5.37% | -11.55% | 4.13% | -10.39% |
| 순이익률 | -6.16% | -4.01% | -13.09% | 0.52% | -14.76% |
| 매출총이익률 | 18.81% | 14.34% | 16.29% | 29.37% | 26.88% |
| 부채비율 | 218.29% | 219.65% | 347.53% | 222.40% | 271.27% |
| 유동비율 | 66.22% | 30.69% | 43.09% | 63.57% | 56.99% |
| 매출 성장률(YoY) | — | 50.20% | -17.70% | 11.87% | -12.99% |
| 영업이익 성장률(YoY) | — | — | — | — | -318.77% |
| 순이익 성장률(YoY) | — | — | — | — | -2561.89% |
| FCF | -350억 | -89.19억 | -40.58억 | -14.19억 | -8.84억 |
| FCF 마진 | -111.90% | -19.01% | -10.51% | -3.28% | -2.35% |
| CAPEX/매출 | 117.43% | 24.34% | 2.17% | 0.68% | 0.68% |
| 항목 | 2021 3Q(별도) | 2021 4Q(별도) | 2022 1Q(별도) | 2022 2Q(별도) | 2022 3Q(별도) | 2022 4Q(별도) | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q(별도) | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q(별도) | 2025 1Q(별도) | 2025 2Q(별도) | 2025 3Q(별도) | 2025 4Q(별도) | 2026 1Q(별도) | 2026 2Q(별도) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.15% | -4.43% | -2.99% | -12.31% | -3.13% | 10.81% | -13.60% | -6.37% | -11.39% | 12.30% | -6.73% | 9.50% | -4.30% | 2.00% | -8.47% | -6.08% | -2.40% | -4.97% | -0.83% | 13.03% |
| ROA | 0.61% | -1.39% | -0.90% | -3.30% | -0.87% | 3.39% | -3.97% | -1.66% | -2.79% | 3.29% | -1.71% | 2.52% | -1.12% | 0.53% | -2.21% | -1.69% | -0.69% | -1.44% | -0.20% | 3.55% |
| 영업이익률 | 8.42% | -40.92% | -3.09% | -9.12% | -2.99% | -5.82% | -18.16% | -20.59% | -44.07% | 4.16% | -5.11% | 5.64% | 6.74% | 8.47% | -16.90% | -22.74% | -8.96% | -0.11% | 3.89% | -0.17% |
| 순이익률 | 6.23% | -19.06% | -6.91% | -26.11% | -8.61% | 31.04% | -47.35% | -21.28% | -56.65% | 17.76% | -15.81% | 19.84% | -11.19% | 4.29% | -25.03% | -21.72% | -6.31% | -10.54% | -1.91% | 30.70% |
| 매출총이익률 | 30.29% | -5.01% | 14.75% | 8.63% | 18.88% | 16.61% | 15.41% | 14.14% | 9.67% | 19.41% | 24.16% | 26.93% | 30.23% | 35.52% | 25.13% | 25.12% | 26.51% | 29.34% | 31.99% | 32.64% |
| 부채비율 | 253.49% | 218.29% | 232.61% | 272.39% | 270.80% | 219.65% | 255.23% | 297.63% | 354.45% | 347.53% | 338.72% | 258.08% | 228.79% | 222.40% | 238.69% | 260.07% | 265.39% | 271.27% | 424.97% | 273.46% |
| 유동비율 | 78.31% | 66.22% | 53.39% | 49.66% | 41.94% | 30.69% | 33.19% | 37.59% | 37.46% | 43.09% | 41.01% | 41.19% | 36.45% | 63.57% | 59.39% | 55.60% | 56.29% | 56.99% | 80.49% | 50.48% |
| 매출 성장률(YoY) | — | — | — | — | 4.24% | 45.54% | -38.75% | -40.73% | -51.24% | 68.04% | 25.31% | 52.65% | 90.47% | -33.16% | -18.16% | -40.17% | 5.71% | 3.88% | 32.69% | 54.99% |
| 영업이익 성장률(YoY) | — | — | — | — | -137.01% | — | — | — | — | — | — | — | — | 36.07% | — | -341.06% | -240.69% | -101.32% | — | — |
| 순이익 성장률(YoY) | — | — | — | — | -244.04% | — | — | — | — | -3.84% | — | — | — | -83.87% | — | -165.49% | — | -355.45% | — | — |
| FCF | -128억 | -29.71억 | -28.44억 | -22.49억 | -61.71억 | 23.44억 | -29.34억 | -22.2억 | -31.17억 | 42.13억 | — | — | 3억 | -16.28억 | 14.01억 | -34.97억 | -9.63억 | 18.68억 | -15.31억 | -25.97억 |
| FCF 마진 | -134.30% | -40.58% | -21.49% | -17.18% | -62.11% | 22.00% | -36.20% | -28.60% | -64.34% | 23.53% | — | — | 3.25% | -13.61% | 16.85% | -49.34% | -9.87% | 15.02% | -13.88% | -23.64% |
| CAPEX/매출 | 111.50% | 58.48% | 28.70% | 20.41% | 22.02% | 25.94% | 4.89% | 0.36% | 1.01% | 2.03% | — | — | 0.72% | 1.00% | 2.30% | 2.49% | 1.57% | 0.32% | 0.15% | 2.87% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 00:30· 별도 · 산식은 항목 툴팁